China
· Delayed Price · Currency is CNY Mingchen Health Statistics
Total Valuation
Mingchen Health has a market cap or net worth of CNY 4.53 billion. The enterprise value is 4.39 billion.
| Market Cap | 4.53B |
| Enterprise Value | 4.39B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
Mingchen Health has 266.02 million shares outstanding. The number of shares has decreased by -4.12% in one year.
| Current Share Class | 266.02M |
| Shares Outstanding | 266.02M |
| Shares Change (YoY) | -4.12% |
| Shares Change (QoQ) | +9.72% |
| Owned by Insiders (%) | 48.80% |
| Owned by Institutions (%) | 13.39% |
| Float | 124.19M |
Valuation Ratios
The trailing PE ratio is 299.42.
| PE Ratio | 299.42 |
| Forward PE | n/a |
| PS Ratio | 3.29 |
| PB Ratio | 5.42 |
| P/TBV Ratio | 8.32 |
| P/FCF Ratio | 52.54 |
| P/OCF Ratio | 31.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 169.91, with an EV/FCF ratio of 50.94.
| EV / Earnings | 300.19 |
| EV / Sales | 3.18 |
| EV / EBITDA | 169.91 |
| EV / EBIT | n/a |
| EV / FCF | 50.94 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.46 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | 0.28 |
| Interest Coverage | 6.44 |
Financial Efficiency
Return on equity (ROE) is 1.74% and return on invested capital (ROIC) is 0.60%.
| Return on Equity (ROE) | 1.74% |
| Return on Assets (ROA) | 0.44% |
| Return on Invested Capital (ROIC) | 0.60% |
| Return on Capital Employed (ROCE) | 0.98% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | 11,555 |
| Employee Count | 1,267 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 4.73 |
Taxes
| Income Tax | -19.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.04% in the last 52 weeks. The beta is 0.21, so Mingchen Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +22.04% |
| 50-Day Moving Average | 15.72 |
| 200-Day Moving Average | 15.53 |
| Relative Strength Index (RSI) | 58.14 |
| Average Volume (20 Days) | 5,706,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mingchen Health had revenue of CNY 1.38 billion and earned 14.64 million in profits. Earnings per share was 0.06.
| Revenue | 1.38B |
| Gross Profit | 680.18M |
| Operating Income | 8.37M |
| Pretax Income | -4.99M |
| Net Income | 14.64M |
| EBITDA | 7.27M |
| EBIT | 8.37M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 162.04 million in cash and 23.77 million in debt, giving a net cash position of 138.27 million or 0.52 per share.
| Cash & Cash Equivalents | 162.04M |
| Total Debt | 23.77M |
| Net Cash | 138.27M |
| Net Cash Per Share | 0.52 |
| Equity (Book Value) | 836.08M |
| Book Value Per Share | 3.14 |
| Working Capital | 392.51M |
Cash Flow
In the last 12 months, operating cash flow was 143.38 million and capital expenditures -57.11 million, giving a free cash flow of 86.27 million.
| Operating Cash Flow | 143.38M |
| Capital Expenditures | -57.11M |
| Free Cash Flow | 86.27M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 49.29%, with operating and profit margins of 0.61% and 1.06%.
| Gross Margin | 49.29% |
| Operating Margin | 0.61% |
| Pretax Margin | -0.36% |
| Profit Margin | 1.06% |
| EBITDA Margin | 0.53% |
| EBIT Margin | 0.61% |
| FCF Margin | 6.25% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | -66.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 227.23% |
| Buyback Yield | 4.12% |
| Shareholder Yield | 4.42% |
| Earnings Yield | 0.32% |
| FCF Yield | 1.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 31, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | May 31, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Mingchen Health has an Altman Z-Score of 10.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.54 |
| Piotroski F-Score | 5 |